Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 1, 2003

Published online before print September 12, 2003
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0403138v1
74/6/1008    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shams, H.
Right arrow Articles by Wizel, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shams, H.
Right arrow Articles by Wizel, B.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0403138


Received for publication April 4, 2003.
Revised July 3, 2003.
Accepted for publication August 4, 2003.


Article

Human CD8+ T cells recognize epitopes of the 28-kDa hemolysin and the 38-kDa antigen of Mycobacterium tuberculosis

Homayoun Shams *{dagger}@, Peter F. Barnes *{dagger}{ddagger}, Stephen E. Weis §, Peter Klucar *{dagger}, and Benjamin Wizel *{dagger}

*Center for Pulmonary and Infectious Disease Control, Departments of {dagger}Microbiology and Immunology and {ddagger}Medicine, University of Texas Health Center, Tyler; and §Department of Internal Medicine, University of North Texas Health Sciences Center, Fort Worth

@ To whom correspondence should be addressed. E-mail: amir.shams{at}uthct.edu.


   Abstract

Mycobacterium tuberculosis antigens that are recognized by human CD8+ T cells are potentially important vaccine target molecules. We used a motif-based strategy to screen selected proteins of M. tuberculosis for peptides predicted to bind to human leukocyte antigen (HLA)-A*0201. We identified two 10 amino acid peptides that elicited cytolytic T lymphocyte activity and interferon-{gamma} production by CD8+ T cells from HLA-A*0201+ healthy tuberculin reactors. These peptides were derived from the 38-kDa antigen and the 28-kDa hemolysin, the latter being a novel target for CD8+ T cells. We speculate that hemolysins may alter the phagosomal membrane surrounding intracellular M. tuberculosis, allowing themselves and other antigens to gain access to the major histocompatibility complex class I processing pathway.

Key Words: cytolytic T lymphocyte • HLA-A*0201 • bacillus Calmette-Guerin







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2003 by the Society for Leukocyte Biology.